Obituary for Charles Aubrey LeMaistre, M.D.
Charles Aubrey LeMaistre, M.D.
1924-2017
Charles Aubrey “Mickey” LeMaistre, M.D., beloved physician, father, trusted friend and husband, passed away in Houston on January 28, 2017, less than two weeks before his 93rd birthday. Mickey was the epitome of a man who cared for others and practiced great discipline in his life.
Mickey LeMaistre’s career began at age 10, as a deckhand spotting fish for tourists in Hogtown...
Two migration proteins boost predictive value of pancreatic cancer biomarker
Adding two blood-borne proteins associated with cancer cell migration increases the predictive ability of the current biomarker for pancreatic...
Study reveals PGK1 enzyme as therapeutic target for deadliest brain cancer
Discovery of a dual role played by the enzyme phosphoglycerate kinase 1 (PGK1) may indicate a new therapeutic target for glioblastoma, an...
Lung cancer cells susceptible to inhibitor treatment via newly discovered pathway
Next-generation cyclin dependent kinase 2/9 (CDK2/9) inhibitors offer a novel way to treat lung cancer with minimal toxic side effects on normal cells, according to a laboratory study by researchers at The University of Texas MD Anderson Cancer Center. The examined inhibitors were effective in stopping growth of lung cancer cells through induced anaphase catastrophe, a cellular pathway discovered at MD Anderson.
One of these highly...
Gut bacteria associated with cancer immunotherapy response in melanoma
Melanoma patients’ response to a major form of immunotherapy is associated with the diversity and makeup of trillions of potential allies...
Hormonal maintenance therapy may improve survival in women with chemo-resistant rare ovarian or peritoneum cancer
For women with a rare subtype of epithelial ovarian or peritoneum cancer, known as low-grade serous carcinoma (LGSC), hormone maintenance...
MD Anderson receives $19.5 million in CPRIT funding for recruitment and prevention
The University of Texas MD Anderson Cancer Center this week was awarded $19.5 million from the Cancer Prevention and Research Institute of...
More patients with early-stage breast cancer may be able to avoid chemotherapy in the future
Women with early-stage breast cancer who had an intermediate risk recurrence score (RS) from a 21-gene expression assay had similar outcomes...
MD Anderson designated first Project ECHO superhub for oncology
Recognizing a critical need to address disparities in cancer care, The University of Texas MD Anderson Cancer Center has been designated as...
Scientists identify aggressive pancreatic cancer cells and their vulnerability
Researchers have identified a gatekeeper protein that prevents pancreatic cancer cells from transitioning into a particularly aggressive cell...
Breast cancer patients with dense breast tissue more likely to develop contralateral disease
Breast cancer patients with dense breast tissue have almost a two-fold increased risk of developing disease in the contralateral breast, according...
MD Anderson to present Making Cancer History® Seminar in Indian Wells
The University of Texas MD Anderson Cancer Center returns to Southern California this month with its Making Cancer History® Seminar, 3:30-...
Researchers identify ‘synthetic essentiality’ as novel approach for locating cancer therapy targets
A new method has been found for identifying therapeutic targets in cancers lacking specific key tumor suppressor genes. The process, which...
MD Anderson supports World Cancer Day with allies around the globe
In honor of World Cancer Day on Feb. 4, The University of Texas MD Anderson Cancer Center calls for health care providers, organizations,...
Dr. Stephen Hahn joins MD Anderson senior leadership team
The University of Texas MD Anderson Cancer Center today announced the appointment of Stephen Hahn, M.D., to the senior leadership role of...